Ophthalmic Medical Technologists (f/m/x)

Hungary

Apply with AI Apply

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Medical Imaging, Clinical ResearchIndustries

Requirements

Candidates should have an Associate's or Bachelor's degree and at least 2 years of experience as an Ophthalmic Imaging Technologist or relevant clinical trial experience. Preferred qualifications include experience with ophthalmic imaging modalities such as OCT and fundus photography, proficiency in computer software like Word, Excel, and Access, and experience in clinical trials or the pharmaceutical industry.

Responsibilities

Ophthalmic Medical Technologists will review and analyze ophthalmic image data for clarity and quality, ensuring compliance with project protocols and generating image queries when necessary. They will work with therapeutic teams to resolve quality issues, assist in data archiving, and potentially support other image analysis functions like client demonstrations and image preparation for submission. Additionally, they will help identify and communicate project requirements related to image quality review processes, support technical imaging issues, conduct study initiation/technical visits to educate site personnel, and assist in the design and implementation of study-related forms and imaging guidelines. Maintaining quality service and departmental standards includes adhering to SOPs, assisting in establishing departmental standards, participating in user acceptance testing for new tools, and modifying company SOPs related to image quality review.

Skills

Ophthalmic imaging

Image analysis

Protocol compliance

Quality assurance

Data archiving

Image acquisition

Standard Operating Procedures (SOPs)

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free